Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BMS-954561 in Post-herpetic Neuralgia
NCT01305538Phase 2Completed
- Sponsor
- Bristol Myers Squibb
- Start
- Mar 2011
- Primary completion
- Feb 2012
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of BMS-954561 in postherpetic neuralgia (PHN), sponsored by Bristol Myers Squibb. Started Mar 2011; status: completed.
02
Drugs
BMS-954561
03
Conditions
postherpetic neuralgia (PHN)
Beyond the preview
Go deeper on NCT01305538.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01305538.